Hundreds of products containing Valsartan, a popular drug for treating high blood pressure and heart failure, have been recalled in more than 20 countries due to impurities in the medications that are linked to cancer and other serious medical problems. The recalled Valsartan pills were manufactured overseas in China and India, and the unexpected contamination with carcinogenic impurities is believed to be due to changes a major Chinese manufacturer made to the way the drug was made. According to reports, these manufacturing changes were made as far back as 2012, which means the recalled Valsartan-containing products may have contained these impurities for years. If you or a loved one has developed stomach cancer, colorectal cancer, pancreatic cancer, liver failure or another serious medical issue while taking contaminated Valsartan, contact an experienced Valsartan injury lawyer as soon as possible to discuss the possibility of pursuing compensation through a product liability lawsuit.
July 2018 – European countries begin recalling contaminated Valsartan products after certain batches of the drug were found to contain NDMA.
July 2018 – The FDA issues a nationwide recall of Valsartan after finding the cancer-causing impurity NDMA in drug products containing Valsartan.
August 2018 – The FDA includes hundreds of U.S. drug products in the Valsartan recall.
August 2018 –Hetero Labs Limited of India, which used a manufacturing process similar to ZHP of China’s, is named as an additional source of the Valsartan contamination.
September 2018 – A second carcinogen (NDEA) is found in the recalled Valsartan products.
September 2018 – The European Medicines Agency (EMA) announces that it will review four other medications related to Valsartan (Irbesartan, Losartan, Candesartan and Olmesartan).
September 2018 – The FDA bans ZHP of China from importing Valsartan or any other medications into the United States after an inspection of ZHP of China facilities uncovered numerous violations.
October 2018 – The FDA announces an additional recall of certain batches of Irbesartan, a similar, non-Valsartan drug also used to treat high blood pressure.
December 2018 – The FDA announces a recall of Losartan after finding nitrosamines in the medication.
February 2019 – Another cancer-causing impurity, NMBA, is found in Losartan.
July 2017 – The authors of a Chinese study note that “Nitrosamines such as N-Nitrosodimethylamine (NDMA) in drinking water have recently attracted great attention because of their high carcinogenicity and high detection rate.”
September 2018 – A Danish nationwide cohort study indicates that exposure to NDMA can cause cancer of the liver, colon, pancreas, stomach and rectum.
January 2019 – The Open Access Macedonian Journal of Medical Sciences publishes a study highlighting the potential for irbesartan treatment to cause melanoma in users.
April 2019 – A study published in the Biological & Pharmaceutical Bulletin indicates that NDMA is believed to have been introduced into valsartan drug products due to the process by which the active pharmaceutical ingredient is manufactured.
April 2019 – Research conducted by MD Anderson Cancer Center notes “significant positive associations of NDEA and NDMA with a risk of pancreatic cancer.”
Patients who took contaminated Valsartan pills are now filing lawsuits against the drug companies and pharmacies who made and sold the defective medications. Plaintiffs in the Valsartan lawsuits are seeking compensatory damages for their injuries and pain and suffering, in addition to punitive damages to punish the drug manufacturers, distributors and retailers for negligently selling dangerous drugs containing cancer-causing chemicals. Valsartan lawsuits allege that:
Exposure to toxic chemicals found in recalled Valsartan products could increase patients’ risk of developing cancer of the liver, kidney, colon, stomach or gastrointestinal tract, among other serious illnesses, and if you have been exposed to contaminated Valsartan, you should discuss your treatment with your doctor right away. If you developed cancer or suffered liver damage while taking Valsartan or another angiotensin II receptor blocker, you should contact a knowledgeable Valsartan injury lawyer to discuss your legal options. You may have grounds to file a Valsartan lawsuit against the company that manufactured, promoted, marketed and sold the contaminated medication, and our consumer advocates at the Consumer Justice Foundation can help. We are committed to protecting the rights of innocent consumers harmed by defective and dangerous medications, and we can help put you in touch with an experienced Valsartan attorney.